• Biogen Pharmachem shareholders approved a 1:6 bonus share issue via postal ballot with 99.99% votes in favor.
• Members also approved increasing authorized share capital and altering the MOA with 100% favorable votes.
• M/S. Goenka Mehta & Associates appointed as new statutory auditors following previous auditor's medical resignation.
• The postal ballot e-voting was conducted from March 27 to April 25, 2026, with results declared on April 27, 2026.